MTOR and colorectal carcinoma: When activated, PI3K/Akt leads to the inhibition of pro-apoptotic factors, and stimulates mTOR (mammalian target of rapamycin), promoting cell growth and protein synthesis—processes essential for tumor development and metastatic potential in CRC (90).